As part of its broader strategy to address the opioid crisis, the U.S. Food and Drug Administration has issued draft guidance titled 'Development of Non-Opioid Analgesics for Chronic Pain' to accelerate safe and effective non-opioid treatments and to reduce prescription-related opioid misuse.
The new draft guidance emphasizes efficient drug development approaches, with specific attention to trial design, appropriate patient populations, and meaningful outcomes- such as reducing the need for opioid use.
For comments and feedback contact: editorial@rttnews.com
Health News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.